Works matching AU Eikelboom, John W.

Results: 148
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.

    Published in:
    JAMA Network Open, 2020, v. 3, n. 9, p. e2015943, doi. 10.1001/jamanetworkopen.2020.15943
    By:
    • Hijazi, Ziad;
    • Oldgren, Jonas;
    • Lindbäck, Johan;
    • Alexander, John H.;
    • Alings, Marco;
    • De Caterina, Raffaele;
    • Eikelboom, John W.;
    • Ezekowitz, Michael D.;
    • Held, Claes;
    • Huber, Kurt;
    • Hylek, Elaine M.;
    • Granger, Christopher B.;
    • Lopes, Renato D.;
    • Vinereanu, Dragos;
    • Siegbahn, Agneta;
    • Wallentin, Lars
    Publication type:
    Article
    16
    17

    Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial.

    Published in:
    Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296211073922
    By:
    • Ramacciotti, Eduardo;
    • Agati, Leandro Barile;
    • Volpiani, Giuliano Giova;
    • Brito, Karen Falcão;
    • Ribeiro, Camilla Moreira;
    • Aguiar, Valéria Cristina Resende;
    • Ramacciotti, Lorenzo Storino;
    • Paganotti, Alexia;
    • Pereira, Felipe Menegueti;
    • Caffaro, Roberto Augusto;
    • Fioranelli, Alexandre;
    • Krakauer, Rogério;
    • Rached, Heron Rhydan Saad;
    • Wolosker, Nelson;
    • Anand, Sonia S.;
    • Eikelboom, John W.;
    • Lopes, Renato Delascio
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 424, doi. 10.1111/bjh.17847
    By:
    • Ying, Lianghong;
    • Wang, Jing;
    • Li, Juan;
    • Teng, Jianzhen;
    • Zhang, Xiaofeng;
    • Ullah, Inam;
    • Samee, Abdus;
    • Xu, Ke;
    • Chen, Jun;
    • Xu, Lei;
    • Zhu, Hui;
    • Li, Jimin;
    • Yang, Lu;
    • Wang, Fei;
    • Fan, Yuansheng;
    • Zhang, Jing;
    • Lu, Yi;
    • Gong, Xiaoxuan;
    • Shi, Lu;
    • Eikelboom, John W.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Tranexamic acid and rosuvastatin in patients at risk of cardiovascular events after noncardiac surgery: a pilot of the POISE-3 randomized controlled trial.

    Published in:
    Pilot & Feasibility Studies, 2020, v. 6, n. 1, p. 1, doi. 10.1186/s40814-020-00643-9
    By:
    • Marcucci, Maura;
    • Duceppe, Emmanuelle;
    • Le Manach, Yannick;
    • Kearon, Clive;
    • Eikelboom, John W.;
    • Pohl, Kayla;
    • Vincent, Jessica;
    • Darvish-Kazem, Saeed;
    • Srinathan, Sadeesh K.;
    • Neary, John D. D.;
    • Parlow, Joel L.;
    • Kurz, Andrea;
    • Gross, Peter L.;
    • Mrkobrada, Marko;
    • Balasubramanian, Kumar;
    • Sessler, Daniel I.;
    • Devereaux, P. J.
    Publication type:
    Article
    32
    33

    The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial.

    Published in:
    Clinical Drug Investigation, 2022, v. 42, n. 11, p. 977, doi. 10.1007/s40261-022-01209-8
    By:
    • van Broekhoven, Amber;
    • Mohammadnia, Niekbachsh;
    • Silvis, Max J. M.;
    • Los, Jonathan;
    • Fiolet, Aernoud T. L.;
    • Opstal, Tjerk S. J.;
    • Mosterd, Arend;
    • Eikelboom, John W.;
    • Nidorf, Stefan M.;
    • Budgeon, Charley A.;
    • Byrnes, Elizabeth;
    • Bax, Willem A.;
    • Tijssen, Jan G. P.;
    • de Kleijn, Dominique P. V.;
    • Thompson, Peter L.;
    • El Messaoudi, Saloua;
    • Cornel, Jan H.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40

    Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.

    Published in:
    European Heart Journal, 2023, v. 44, n. 20, p. 1807, doi. 10.1093/eurheartj/ehad200
    By:
    • Benz, Alexander P;
    • Hohnloser, Stefan H;
    • Eikelboom, John W;
    • Carnicelli, Anthony P;
    • Giugliano, Robert P;
    • Granger, Christopher B;
    • Harrington, Josephine;
    • Hijazi, Ziad;
    • Morrow, David A;
    • Patel, Manesh R;
    • Seiffge, David J;
    • Shoamanesh, Ashkan;
    • Wallentin, Lars;
    • Yi, Qilong;
    • Connolly, Stuart J
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47

    Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial.

    Published in:
    European Heart Journal, 2020, v. 41, n. 30, p. 2848, doi. 10.1093/eurheartj/ehaa247
    By:
    • Böhm, Michael;
    • Brueckmann, Martina;
    • Eikelboom, John W;
    • Ezekowitz, Michael;
    • Fräßdorf, Mandy;
    • Hijazi, Ziad;
    • Hohnloser, Stefan H;
    • Mahfoud, Felix;
    • Schmieder, Roland E;
    • Schumacher, Helmut;
    • Wallentin, Lars;
    • Yusuf, Salim
    Publication type:
    Article
    48
    49
    50